DALY II (MB-CART2019.1)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DALY II (MB-CART2019.1), covering 2025-04-24 to 2025-04-24. Get the full timeline:
Most recent: Clinical Trial Update: DALY II USA/ MB-CART2019.1 for DLBCL [Phase 2]